Madras High Court revokes ban on manufacture and sale of paediatric drugs nimesulide and PPA

Tuesday, September 13, 2011

Madras High Court has revoked a ban on manufacture and sale of paediatric drugs nimesulide and phenylpropanolamine (PPA). Early this year, the union health ministry had banned sale of anti-inflammatory drug nimesulide for use in children below 12 years of age and decongestant formulation PPA used in cough syrups citing their adverse impacts on human health, including liver toxicity.

The ban was challenged by writ petitions filed by drug makers Cipla and Unichem.

“It is paramount consideration for the government to arrive at a subjective satisfaction in public interest,” Madras High Court said in its judgement, adding that the matter was not discussed with concerned parties.

The ban by the government is without proper recommendation and hence illegal, said advocate AA Mohan of Mohan Associates, a representative of Unichem in the case.

“The ban on PPA without any reported side effects in India is completely un-thought of in as much as the drug PPA which is in use for the last 20 years does not have any reported side effects,” said Cipla in its affidavit.

The total market for nimesulide in India is nearly Rs 300 crore.

Nimesulide is banned in developed nations such as the UK, Canada, New Zealand, Australia and Denmark. [Source: Economic Times]

Categories: NEWS, Pharmaceuticals

Tags: , , , , , ,

  More from NEWS

Next generation optical biometry devices market may grow to $450 million by 2028

Healthcare should be a mission with ethical & moral values: Rajnath Singh

Biosense Technologies raises $1 million in funding

World No Tobacco Day celebrated at ESIC Medical College

Pune doctors perform India’s first uterus transplant surgery

ICMR to test efficacy of two medicines for tackling drug-resistant TB

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.